Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from Lean and Obese Rat Mammary Glands, with and without treatment with bazedoxifene + conjugated estrogens (BZA/CE)

ABSTRACT: Expression data from Lean and Obese Rat Mammary Glands, with and without treatment with bazedoxifene + conjugated estrogens (BZA/CE)

PROVIDER: PRJNA1230742 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression data from Lean and Obese Rat Mammary Glands, with and without treatment with bazedoxifene + conjugated estrogens (BZA/CE)

Project description:Many risk-eligible women refuse tamoxifen for primary prevention of breast cancer due to concerns about common side effects such as vasomotor symptoms. Tamoxifen may also induce or worsen insulin resistance and hypertriglyceridemia, especially in women with obesity. Bazedoxifene/conjugated estrogens (BZA/CE) reduces vasomotor symptoms and is currently undergoing evaluation for breast cancer risk reduction. However, the impact of BZA/CE on insulin resistance and metabolic health, particularly in those with excess adiposity, is understudied. Here, we examined the effects of obesity on response to BZA/CE in a rat model of breast cancer risk using older ovary-intact rats. Female Wistar rats received carcinogen to increase mammary cancer risk and were fed a high-fat diet to promote obesity. Lean and obese rats were selected based on adiposity, then randomized to BZA/CE or vehicle for 8 weeks. BZA/CE reduced adiposity, enriched small (insulin-sensitive) mammary adipocytes, increased the abundance of beneficial metabolic gut microbes (Faecalbaculum rodentium and Odoribacter laneus), and reversed obesity-associated changes in lipids and adipokines. BZA/CE also reversed obesity-induced mammary enrichment of cell proliferation pathways, consistent with risk-reducing effects. Together, these data support the use of BZA/CE to improve metabolic health and reduce breast cancer risk in individuals with obesity. RNA from mammary glands was analyzed by gene expression microarray.

2025-04-30 | GSE290908 | GEO

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [microbiota]

Project description:Bazedoxifene and conjugated estrogens (CE+BZA) combination has been shown to prevent visceral adiposity and weight gain after menopause. However, its interaction with the microbiota has yet to be examined. In the present study, we use several –omics technologies to characterize the effects of various estrogens on the health of gut-liver axis. As reported in previous studies, CE+BZA combination is very effective at preventing ovariectomy-induced weight gain in mice fed a high-fat diet. Additionally, CE+BZA induces unique liver transcriptomic and blood metabolite profiles compared to estradiol, conjugated estrogens alone, and bazedoxifene alone. Several pathways and metabolites influenced are associated with lower rates of inflammation and overall benefits to gut and liver health. Finally, microbiome analysis shows that several bacterial species that potentially metabolize estrogens and affect their half-life in the body were significantly changed in CE+BZA treated mice. Our findings indicate a possible link between certain estrogens and gut microbiome and suggest a metabolic benefit of estrogens through manipulation of the gut-liver axis.

2019-12-28 | GSE93096 | GEO

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health [mouse liver]

2018-02-13 | GSE92968 | GEO

Bazedoxifene and conjugated estrogen combination improves gut-liver axis health

Project description:Bazedoxifene and conjugated estrogen combination improves gut-liver axis health

| PRJNA360113 | ENA

Candidatus Carsonella ruddii CE isolate Thao2000 strain:CE

Project description:Candidatus Carsonella ruddii CE isolate Thao2000 strain:CE Genome sequencing

| PRJNA165179 | ENA

Acinetobacter sp. CE-15

Project description:Acinetobacter sp. CE-15 Genome sequencing

| PRJNA1266666 | ENA

DNA and histone modifications identify a putative controlling element (CE) on the X chromosome of Sciara coprophila

Project description:In Sciara coprophila, paternally inherited X chromosomes are imprinted and selectively eliminated during early embryonic development. A controlling element (CE) located on the X chromosome is known to play a decisive role in this process, although the exact mechanism remains unknown. In this study, we test a proposed model in which the maternal cytoplasm regulates CE activity and thereby controls Xp elimination during embryogenesis. Using our de novo Sciara genome assembly, along with ChIP-Seq and MeDIP analyses, we identified a 1.2 Mb region within the CE locus that exhibits a repressive epigenetic signature on X chromosomes that are retained. These findings provide molecular support for the model. Remarkably, this signature also includes a unique enrichment of CpG methylation, suggesting a strong evolutionary conservation of imprinting mechanisms and identifying a promising candidate for the long-sought CE locus responsible for somatic Xp-chromosome elimination.

2025-06-11 | GSE299219 | GEO

Bradyrhizobium sp. Ce-3

Project description:Draft Genome Sequence of Bradyrhizobium sp. strain Ce-3

| PRJDB12974 | ENA

Vigna unguiculata cultivar:CE 31

Project description:Vigna unguiculata cultivar:CE 31 Raw sequence reads

| PRJNA803357 | ENA

Metagenomics of 13C-enriched estrogens-contaminated soil

Project description:Metagenomics of 13C-enriched estrogens-contaminated soil

| PRJNA1209520 | ENA